The global market for Peripheral Blood Mononuclear Cells (PBMC) is projected to grow at a CAGR of around 9% during 2020 – 2025 – GlobeNewswire

August 21, 2020 13:04 ET | Source: ReportLinker

New York, Aug. 21, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Peripheral Blood Mononuclear Cells Market, By Product, By Application, By Technique, By Source, By Region, Competition, Forecast & Opportunities, 2025" - https://www.reportlinker.com/p05953172/?utm_source=GNW

The global market for Peripheral Blood Mononuclear Cells (PBMC) is projected to grow at a CAGR of around 9% during 2020 - 2025.The PBMC are crucial to carry out the biology and pathology related studies as well as in clinical research.

Besides, PBMCs are also utilized in research related to fatal diseases, immunology, vaccine development, etc. However, high cost of PBMCs related studies might act as a challenge for the adoption of technology, especially in developing economies. The global peripheral blood mononuclear cells market is segmented based on product, application, technique, source, and region.The product segment is further divided into cryopreserved or frozen PBMC, cultured or fresh PBMC and peripheral blood mononuclear cell isolation & viability kits.

As of 2019, the cryopreserved PBMC or the frozen PBMC segment held the highest market share as they can be used for longer durations of time if stored carefully at lower temperatures.In terms of regional analysis, North America accounted for the largest market share in the year 2019, on the back of a number of pre-existing peripheral blood mononuclear cells-based companies in the region.

The economy of the region is also rich enough, which makes it easier to carry out the complex and costly R&D procedures. Major players operating in the global peripheral blood mononuclear cells market include Astarte Biologics, Inc., ATZLabs, BioIVT, BioLegend, Inc., BioVision, Bio-Rad, Cell Applications, Inc., Celgene, Creative Bioarray, Dapcel, Inc, HemaCare, iXCells Biotechnologies, Miltenyi Biotec, Merck, Novo Nordisk, Precision Medicine, Qiagen NV, STEMCELL Technologies Inc., Thermo Fisher Scientific, ZenBio, Inc., etc.

Years considered for this report:

Historical Years: 2015 - 2018 Base Year: 2019 Estimated Year: 2020 Forecast Period: 2021 - 2025

Objective of the Study:

To analyze and forecast the market size of global peripheral blood mononuclear cells market. To classify and forecast global peripheral blood mononuclear cells market based on product, application, technique, source, and region. To identify drivers and challenges for global peripheral blood mononuclear cells market. To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global peripheral blood mononuclear cells market. To conduct pricing analysis for global peripheral blood mononuclear cells market. To identify and analyze the profile of leading players operating in global peripheral blood mononuclear cells market. The analyst performed both primary as well as exhaustive secondary research for this study.Initially, the analyst sourced a list of leading market players across the globe.

Subsequently, the analyst conducted primary research surveys with the identified companies.While interviewing, the respondents were also enquired about their competitors.

Through this technique, the analyst could include the research organizations and companies which could not be identified due to the limitations of secondary research. The analyst examined the research organizations and companies, and presence of all major players across the globe. The analyst calculated the market size of global peripheral blood mononuclear cells market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The analyst sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size.

Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the analyst.

Key Target Audience:

Biotechnology and pharma companies and other stakeholders Government bodies such as regulating authorities and policy makers Organizations, forums and alliances related to peripheral blood mononuclear cells Market research and consulting firms The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as research organizations & companies and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global peripheral blood mononuclear cells market has been segmented into following categories, in addition to the industry trends which have also been detailed below: Market, By Product: o Cryopreserved or Frozen PBMC o Cultured or Fresh PBMC o Peripheral Blood Mononuclear Cell Isolation & Viability Kits Market, By Application: o Immunology o Infectious disease o Hematology o Others Market, By Technique: o Density gradient centrifugation process o Leukapheresis Market, By Source: o Human o Animals Market, By Region: o Asia-Pacific - China - India - Japan - South Korea - Singapore - Australia o Europe - France - Germany - United Kingdom - Italy o North America - United States - Mexico - Canada o South America - Brazil - Argentina - Colombia o Middle east & Africa - South Africa - Saudi Arabia - UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global peripheral blood mononuclear cells market.

Available Customizations:

With the given market data, we offers customizations according to a companys specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five). Read the full report: https://www.reportlinker.com/p05953172/?utm_source=GNW

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Visit link:
The global market for Peripheral Blood Mononuclear Cells (PBMC) is projected to grow at a CAGR of around 9% during 2020 - 2025 - GlobeNewswire

Stanford Children’s Health Appoints New Chief of Pediatric Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine – PRNewswire

Gruber brings a wealth of clinical and laboratory experience from St. Jude Children's Research Hospital, where she worked for more than a decade, most recently as an Associate Member of the Molecular Oncology Division in the Oncology Department. While at St. Jude, she became a nationally and internationally recognized leader and physician-scientist who ran a research laboratory in addition to national clinical trials.

"I am thrilled to welcome Dr. Gruber to Stanford Children's Health," said Paul King, president and CEO of Stanford Children's Health. "On the heels of opening our new inpatient cancer centerin 2019, Dr. Gruber's leadership as a remarkably accomplished and collaborative physician-scientist will further enhance Stanford Children's Health's ability to offer preeminent, innovative treatment for pediatric cancer, blood diseases, and stem cell transplantation."

Gruber's research focuses on high-risk leukemia and acute megakaryoblastic leukemia (AMKL). Research in her lab at St. Jude led to the identification of CBFA2T3-GLIS2, a novel fusion gene that confers a poor prognosis in pediatric AMKL and a detailed view of the genomic landscape in MLLr leukemia. Her lab also identified bortezomib and vorinostat as active agents in MLLr leukemia with a novel mechanism of action. These data formed the preclinical basis for the multi-institutional clinical trial "Total Therapy for Infants with Acute Lymphoblastic Leukemia," for which patients at Lucile Packard Children's Hospital Stanford were recruited.

"We are tremendously excited about Tanja's arrival. She will be a transformative leader for the Division of Pediatric Hematology, Oncology, and will also play a pivotal role as the Stanford Cancer Institute's new Associate Director for Pediatric Cancer," said Steven Artandi, MD, PhD, director of the Stanford Cancer Institute. "Her expertise as both a laboratory scientist and clinical trialist will bring added strength to our cancer drug discovery efforts, and her background in immunology will enable us to explore new synergies between our adult and pediatric efforts."

"Stanford is an incredibly inspiring place, and I look forward to working with all the physicians and scientists here to develop new treatment approaches and bring them to patients," Gruber said. "The passion for providing excellent patient care rooted in cutting-edge science is clear, and the opportunity to lead a group that is so committed to advancing the field of pediatric cancer and blood diseases is very exciting."

Gruber graduated from the University of Southern California with an MD in Medicine and PhD in Immunology. She completed residency and a fellowship in hematology and oncology at Children's Hospital Los Angeles prior to being recruited by St. Jude.

Media ContactKate DeTrempe [emailprotected] (650) 485-9487

About Stanford Children's HealthStanford Children's Health, with Lucile Packard Children's Hospital Stanfordat its center, is the Bay Area's largest health care system exclusively dedicated to children and expectant mothers. Our network of care includes more than 65 locationsacross Northern California and more than 85 locations in the U.S. Western region. As part of Stanford Medicine, a leading academic health system that also includes Stanford Health Care and Stanford University School of Medicine, we are cultivating the next generation of medical professionals and are at the forefront of scientific research to improve children's health outcomes around the world. We are a nonprofit organization committed to supporting the community through meaningful outreach programs and services and providing necessary medical care to families, regardless of their ability to pay. Discover more at stanfordchildrens.org.

SOURCE Stanford Childrens Health

http://www.stanfordchildrens.org/

More here:
Stanford Children's Health Appoints New Chief of Pediatric Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine - PRNewswire

Catholic Support for Ethically Acceptable Stem Cell Research

Sometimes it is wrongly said that the Catholic Church opposes stem cell research. In fact, the Church supports ethically responsible stem cell research, while opposing any research that exploits or destroys human embryos.

Because the Church opposes deliberately destroying innocent human life at any stage, for research or any other purpose, it opposes embryonic stem cell research as currently conducted. However, when scientists proposed avenues for possibly obtaining embryonic stem cells or their pluripotent equivalent without creating or harming embryos, Catholic leaders were among the first to welcome this idea: http://www.freerepublic.com/focus/f-news/1435477/posts.

The Catholic Church has long supported research using stem cells from adult tissue and umbilical cord blood, which poses no moral problem. Catholic institutions at times have taken the lead in promoting such constructive research, which is already providing cures and treatments for suffering patients:

In October 2005, the Catholic bishops of South Korea said they will raise and donate about $10 million to advancing adult stem cell research: http://www.taipeitimes.com/News/world/archives/2005/10/06/2003274635

South Korea's Catholic Medical Centre announced in June 2005 that it had successfully treated stroke and vascular disease in 64 patients using adult stem cells: http://www.asianews.it/view.php?l=en&art=3491

A March 2005 breakthrough demonstrating the capabilities of adult stem cells in Australia was made possible by a grant of $50,000 (Australian dollars) from the Catholic Archdiocese of Sydney: http://edition.cnn.com/2005/TECH/science/03/21/australia.stemcell/

In February 2005 a major Catholic teaching hospital in Boston, Caritas St. Elizabeth's Medical Center, announced that it had "identified adult stem cells that may have the capacity to repair and regenerate all tissue types in the body": http://www.caritas-semc.org/home/site_content_list_detail.asp?s=2328&ss=324

The U.S. Conference of Catholic Bishops has worked to pass federal legislation creating a nationwide public bank for umbilical cord blood stem cells, for research and the treatment of a wide variety of diseases.

In 2004 Monsignor Thomas Hartman, director of radio and television for the Catholic Diocese of Rockville Centre, founded The Thomas Hartman Foundation for Parkinson's Research. The foundation has raised millions of dollars for adult stem cell research and other avenues for curing Parkinson's disease: http://www.hartmanfoundation.org

Clearly, the Church favors ethically acceptable stem cell research. It opposes destroying some human lives now, on the pretext that this may possibly help other lives in the future. We must respect life at all times, especially when our goal is to save lives.

Follow this link:
Catholic Support for Ethically Acceptable Stem Cell Research

Global Nerve Repair and Regeneration Market 2020-2025: The Potential of Stem Cell Therapy in Nerve Repair and Regeneration Fuels Opportunity -…

DUBLIN--(BUSINESS WIRE)--The "Nerve Repair and Regeneration Market by Products (Nerve Conduits, Nerve Wraps, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation, TENS, TMS), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global nerve repair and regeneration market is projected to reach USD 9,781.2 million by 2025 from USD 6,339.7 million in 2020, at a CAGR of 9.1%

The growth in this market is driven by a high incidence of nerve injuries, a growing prevalence of neurological disorders, an increasing geriatric population, and rising government support for neurologic disorder research.

The biomaterial as a segment is anticipated to grow at the fastest growth rate during the forecast period.

Based on product type, the nerve repair and regenerations market is segmented into neurostimulation and neuromodulation devices and biomaterials. The biomaterials segment is expected to grow at the highest growth rate during the forecast period. This can primarily be attributed to the high incidence of nerve injuries. Rising government support for neurologic disorders is also one of the major factors to drive the growth of the biomaterials market globally.

The internal neurostimulation and neuromodulation segment is accounted for the largest share during the analysis period.

Based on the neurostimulation and neuromodulation application, the nerve repair and regeneration market is segmented the neurostimulation and neuromodulation devices market is segmented into internal neurostimulation and neuromodulation applications and external neurostimulation and neuromodulation applications. The internal neurostimulation and neuromodulation segment is accounted for the largest share during the forecast period. This can primarily be attributed to the increasing incidence of neurological disorders across the globe.

Asia Pacific is estimated to register the highest CAGR during the study period.

In this report, the nerve repair and regeneration market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in the Asia Pacific is projected to grow at the highest growth rate during the forecast period. Economic growth in the countries of this region, large population base, rising prevalence of neurologic diseases, rising standard of living, growing demand for quality medical care, and increasing healthcare spending will drive the market in the region over the forecast period.

Key Topics Covered

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

4.1 Nerve Repair & Regeneration Market Overview

4.2 Nerve Repair & Regeneration Market: Geographic Growth Opportunities

5 Market Overview

5.1 Introduction

5.2 Market Dynamics

5.2.1 Drivers

5.2.1.1 High Incidence of Nerve Injuries

5.2.1.2 Rising Geriatric Population and Subsequent Growth in the Prevalence of Neurological Disorders

5.2.1.3 Rising Government Support for Neurologic Disorder Research

5.2.2 Opportunities

5.2.2.1 Emerging Markets

5.2.2.2 Potential of Stem Cell Therapy in Nerve Repair and Regeneration

5.2.2.3 Rising Research in the Field of Neurology

5.2.3 Challenges

5.2.3.1 Donor-Site Morbidity

5.2.3.2 Difficulties in Treating Large Nerve Gaps

5.2.3.3 Stringent Regulatory Frameworks and Time-Consuming Approval Processes

5.2.3.4 Greater Preference for Drug Therapies Over Nerve Repair and Regeneration Products

5.2.3.5 Dearth of Trained Professionals

5.2.3.6 Product Recalls

5.3 Impact of COVID-19 on the Nerve Repair and Regeneration Market

6 Nerve Repair and Regeneration Market, by Product

6.1 Introduction

6.2 Neurostimulation and Neuromodulation Devices

6.3 Biomaterials

7 Nerve Repair and Regeneration Market, by Application

7.1 Introduction

7.2 Neurostimulation & Neuromodulation Applications

7.3 Nerve Repair & Regeneration Biomaterials Market, by Application

8 Nerve Repair and Regeneration Market, by Region

8.1 Introduction

8.2 North America

8.3 Europe

8.4 Asia-Pacific

8.5 Rest of the World (Row)

9 Competitive Landscape

9.1 Overview

9.2 Market Share Analysis, 2019

9.3 Competitive Scenario

9.3.1 Product Launches and Approvals

9.3.2 Partnerships, Collaborations, Mergers, and Agreements

9.3.3 Expansions

9.3.4 Acquisitions

9.3.5 Other Developments

9.4 Competitive Leadership Mapping (2019)

9.4.1 Visionary Leaders

9.4.2 Innovators

9.4.3 Dynamic Differentiators

9.4.4 Emerging Companies

10 Company Profiles

10.1 Medtronic, plc

10.2 Boston Scientific Corporation

10.3 Abbott Laboratories

10.4 Axogen, Inc.

10.5 Baxter International, Inc.

10.6 Livanova, plc

10.7 Integra Lifesciences

10.8 Polyganics

10.9 Neuropace, Inc.

10.10 Soterix Medical, Inc.

10.11 Nevro Corp.

10.12 Synapse Biomedical, Inc.

10.13 Aleva Neurotherapeutics

10.14 Collagen Matrix, Inc.

10.15 Kerimedical

10.16 Biowave Corporation

10.17 Neurosigma

10.18 Neuronetics, Inc.

10.19 TVNS Technologies GmbH

10.20 Gimer Medical

For more information about this report visit https://www.researchandmarkets.com/r/n8ux49

Originally posted here:
Global Nerve Repair and Regeneration Market 2020-2025: The Potential of Stem Cell Therapy in Nerve Repair and Regeneration Fuels Opportunity -...

Creative Medical Technology Holdings Identifies Novel Mechanism of Action of AmnioStem Adult Stem Cell Product in Stroke – BioSpace

PHOENIX, Aug. 20, 2020 /PRNewswire/ --Creative Medical Technology Holdings Inc., trading under the ticker symbol CELZ, announced today new data demonstrating effective suppression of stroke associated pathological molecules by AmnioStem universal donor stem cells.

Experiments have shown that AmnioStem potently blockes production of cytokines which are associated with brain damage after stroke. In contrast to previously attempted approaches, the data disclosed today demonstrate that AmnioStem effectively reprograms the macrophages from a pathological to a reparative role.

"The brain damage that occurs in stroke is an ongoing process that only begins when the blood supply is occluded. Even after the blocked artery is resolved, an inflammatory cascade initiates that causes ongoing brain damage." Said Thomas Ichim, Ph.D, Chief Scientific Officer of the Company. "Macrophages are key players in causing brain damage after a stroke. The fact that AmnioStem makes macrophages switch from an inflammatory to anti-inflammatory phenotype suggests superior advantages to other regenerative approaches towards this terrible condition."

Previous studies performed by the Company at its BioLabs research facility in San Diego, showed that AmnioStem cells were superior at suppressing production of inflammatory mediators such as TNF-alpha, interferon gamma, and interleukin-12 as compared to other stem cells1. The current studies show that AmnioStem elicits these cytokine changes based on its activities on macrophages.

"Knowing the specific mechanisms by which our cells work in stroke positions us ahead at several levels: Firstly, it allows us a more straightforward pathway to FDA clearance; Secondly, it allows for development of rationalized medical therapeutics and identification of potentially synergistically acting medications; and Thirdly, it allows for enhanced intellectual property protection." Said Timothy Warbington, President and CEO of the Company. "We plan to submit this data for publication and include it in our upcoming FDA IND submission."

About Creative Medical Technology Holdings

Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company specializing in stem cell technology in the fields of urology, neurology and orthopedics and trades on the OTC under the ticker symbol CELZ. For further information about the company, please visit http://www.creativemedicaltechnology.com.

Forward Looking Statements

OTC Markets has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming clinical trials and laboratory results, marketing efforts, funding, etc. Forward-looking statements address future events and conditions and, therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. See the periodic and other reports filed by Creative Medical Technology Holdings, Inc. with the Securities and Exchange Commission and available on the Commission's website at http://www.sec.gov.

Creativemedicaltechnology.com

Caverstem.com

Femcelz.com

Stemspine.com

1https://www.biospace.com/article/releases/creative-medical-technology-holdings-announces-superior-immune-modulatory-of-amniostem-stem-cells-compared-to-other-stem-cell-types/

View original content to download multimedia:http://www.prnewswire.com/news-releases/creative-medical-technology-holdings-identifies-novel-mechanism-of-action-of-amniostem-adult-stem-cell-product-in-stroke-301115553.html

SOURCE Creative Medical Technology Holdings, Inc.

Read more:
Creative Medical Technology Holdings Identifies Novel Mechanism of Action of AmnioStem Adult Stem Cell Product in Stroke - BioSpace

Global Stem Cell Therapy Market 2020-2025 Demand and Insights Analysis Report – Scientect

The Stem Cell Therapy market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. The report provides key statistics on the market status of the Stem Cell Therapy manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Complete report on Stem Cell Therapy market spread across 113 pages, profiling companies and supported with tables and figures is now available @ https://www.insidemarketreports.com/sample-request/9/432826/Stem-Cell-Therapy

Our industry professionals are working reluctantly to understand, assemble and timely deliver assessment on impact of COVID-19 disaster on many corporations and their clients to help them in taking excellent business decisions. We acknowledge everyone who is doing their part in this financial and healthcare crisis.

The global Stem Cell Therapy market 2020 research is a professional and in-depth study on the current state of the industry and provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Stem Cell Therapy market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

This report presents the worldwide Stem Cell Therapy market size (value, production and consumption), splits the breakdown (data status 2015-2019 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porters Five Forces Analysis.

Companies profiled and studied for this Stem Cell Therapy market report include Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Medi-post, Anterogen, Molmed, Takeda (TiGenix), and others.

Major Points covered in this report are as below

The report focuses on global major leading industry players of Stem Cell Therapy market providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Stem Cell Therapy market development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With tables and figures helping analyze worldwide Stem Cell Therapy market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Purchase the copy of this report at: https://www.insidemarketreports.com/buy-now/9/432826/Stem-Cell-Therapy/single

Purchase this Report now by availing up to 40% Discount and free consultation. Offer is valid for Aug 2020 only.

Why Inside Market Reports:

For all your Research needs, reach out to us at:

Email: [emailprotected]

Phone:+1-617-230-0741

Excerpt from:
Global Stem Cell Therapy Market 2020-2025 Demand and Insights Analysis Report - Scientect

Stem Cell Therapy Market 2020 COVID-19 impact analysis, Global Industry Size Estimation, Research Update, Future Scope, Revenue, Pricing Trends,…

The Insight Partners dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

WorldwideStem Cell Therapy MarketAnalysis is a specialized and in-depth study of the Stem Cell Therapy industry with a focus on the global market trend. The report aims to provide an overview of global Stem Cell Therapy Market with detailed market segmentation by product & services /application and geography. The global Stem Cell Therapy Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the Stem Cell Therapy players and offers key trends and opportunities in the market.

Get Sample PDF of Stem Cell Therapy Market @ https://www.theinsightpartners.com/sample/TIPHE100000991/

The stem cell therapy marketwas valued at US$ 1,534.55 million in 2019 and is expected to grow at a CAGR of 16.7% from 2020to 2027 to reach US$ 5,129.66 million by 2027.

Here we have listed the top Stem Cell Therapy Market companies in the world

The List of Companies

Highlights the following key factors:

1) Business description-A detailed description of the companys operations and business divisions.

2) Corporate strategy Analysts summarization of the companys business strategy.

3) SWOT Analysis-A detailed analysis of the companys strengths, weakness, opportunities, and threats.

4) Company history Progression of key events associated with the company.

5) Major products and services-A list of major products, services, and brands of the company.

6) Key competitors A list of key competitors to the company.

7) Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

8) Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 7 years history.

What does this report deliver?

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Stem Cell Therapy Market based on product and application. It also provides market size and forecast till 2027 for overall Stem Cell Therapy Market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America (SAM), which is later sub-segmented by respective countries and segments. The report evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend and provides exhaustive PEST analysis for all five regions.

Table of Content:

Purchase Copy of This Report at:https://www.theinsightpartners.com/buy/TIPHE100000991/

About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Semiconductors, Healthcare, Manufacturing, Automotive and Defense.

Contact Us: Call: +1-646-491-9876 Email:[emailprotected]

See the original post:
Stem Cell Therapy Market 2020 COVID-19 impact analysis, Global Industry Size Estimation, Research Update, Future Scope, Revenue, Pricing Trends,...

Stem Cell And Regenerative Therapy Market Value Projected to Expand by 2019-2024 – Scientect

The global stem cell and regenerative medicines market should grow from $21.8 billion in 2019 to reach $55.0 billion by 2024 at a compound annual growth rate (CAGR) of 20.4% for the period of 2019-2024.

Report Scope:

The scope of this report is broad and covers various type of product available in the stem cell and regenerative medicines market and potential application sectors across various industries. The current report offers a detailed analysis of the stem cell and regenerative medicines market.

The report highlights the current and future market potential of stem cell and regenerative medicines and provides a detailed analysis of the competitive environment, recent development, merger and acquisition, drivers, restraints, and technology background in the market. The report also covers market projections through 2024.

Get Access to sample pages @ https://www.trendsmarketresearch.com/report/sample/11723

The report details market shares of stem cell and regenerative medicines based on products, application, and geography. Based on product the market is segmented into therapeutic products, cell banking, tools and reagents. The therapeutics products segments include cell therapy, tissue engineering and gene therapy. By application, the market is segmented into oncology, cardiovascular disorders, dermatology, orthopedic applications, central nervous system disorders, diabetes, others

The market is segmented by geography into the following regions: North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. The report presents detailed analyses of major countries such as the U.S., Canada, Mexico, Germany, the U.K. France, Japan, China and India. For market estimates, data is provided for 2018 as the base year, with forecasts for 2019 through 2024. Estimated values are based on product manufacturers total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Report Includes:

28 data tables An overview of global markets for stem cell and regenerative medicines Analyses of global market trends, with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024 Details of historic background and description of embryonic and adult stem cells Information on stem cell banking and stem cell research A look at the growing research & development activities in regenerative medicine Coverage of ethical issues in stem cell research & regulatory constraints on biopharmaceuticals Comprehensive company profiles of key players in the market, including Aldagen Inc., Caladrius Biosciences Inc., Daiichi Sankyo Co. Ltd., Gamida Cell Ltd. and Novartis AG

Summary

The global market for stem cell and regenerative medicines was valued at REDACTED billion in 2018. The market is expected to grow at a compound annual growth rate (CAGR) of REDACTED to reach approximately REDACTED billion by 2024. Growth of the global market is attributed to the factors such as growingprevalence of cancer, technological advancement in product, growing adoption of novel therapeuticssuch as cell therapy, gene therapy in treatment of chronic diseases and increasing investment fromprivate players in cell-based therapies.

In the global market, North America held the highest market share in 2018. The Asia-Pacific region is anticipated to grow at the highest CAGR during the forecast period. The growing government funding for regenerative medicines in research institutes along with the growing number of clinical trials based on cell-based therapy and investment in R&D activities is expected to supplement the growth of the stem cell and regenerative market in Asia-Pacific region during the forecast period.

Reasons for Doing This Study

Global stem cell and regenerative medicines market comprises of various products for novel therapeutics that are adopted across various applications. New advancement and product launches have influenced the stem cell and regenerative medicines market and it is expected to grow in the near future. The biopharmaceutical companies are investing significantly in cell-based therapeutics. The government organizations are funding research and development activities related to stem cell research. These factors are impacting the stem cell and regenerative medicines market positively and augmenting the demand of stem cell and regenerative therapy among different application segments. The market is impacted through adoption of stem cell therapy. The key players in the market are investing in development of innovative products. The stem cell therapy market is likely to grow during the forecast period owing to growing investment from private companies, increasing in regulatory approval of stem cell-based therapeutics for treatment of chronic diseases and growth in commercial applications of regenerative medicine.

Products based on stem cells do not yet form an established market, but unlike some other potential applications of bioscience, stem cell technology has already produced many significant products in important therapeutic areas. The potential scope of the stem cell market is now becoming clear, and it is appropriate to review the technology, see its current practical applications, evaluate the participating companies and look to its future.

The report provides the reader with a background on stem cell and regenerative therapy, analyzes the current factors influencing the market, provides decision-makers the tools that inform decisions about expansion and penetration in this market.

See the rest here:
Stem Cell And Regenerative Therapy Market Value Projected to Expand by 2019-2024 - Scientect

Israelis and Emiratis to develop COVID-19 stem-cell therapy – JNS.org

(August 19, 2020 / Israel21c) Fast on the heels of the agreement between Israel and the United Arab Emirates (UAE) to establish full diplomatic relations, Haifa-based Pluristem Therapeutics has signed a non-binding memorandum of understanding (MoU) with the Abu Dhabi Stem Cells Center to advance cell therapies for diseases including COVID-19.

The aim of the collaboration is to capitalize on each companys respective areas of expertise in cell therapies to deliver regenerative medicine for the benefit not only of the citizens of the UAE and Israel, but for humanity as a whole, Pluristem explained in a press release on Aug. 17.

Pluristem has treated patients with its placental PLX-PAD allogenic product via compassionate-use programs in Israel and the United States and is currently conducting phase II studies in the United States and European Union.

Abu Dhabi Stem Cells Center has been treating COVID-19 patients with stem cells sourced from the patients blood, by returning the cells back into the patients lungs as a fine mist through a nebulizer.

Subscribe to The JNS Daily Syndicate by email and never miss our top stories

The collaboration, initiated by the Better Alternatives advisory firm, would involve exchanging research results, patient samples and testing equipment.

I believe it is our obligation and privilege as business and scientific leaders to lead the way forward to strengthen collaborations and promote innovation and education. We are honored to be on the front line of this historical moment, said Pluristem CEO and President Yaky Yanay.

This is not the first COVID-related joint project between the two countries.

In July, Rafael Advanced Defense Systems and Israel Aerospace Industries signed agreements with Abu Dhabis Group 42 concerning R&D collaborations for solutions to SARS-CoV-2, the virus that causes COVID-19. On Aug. 15, UAEs APEX National Investment signed a strategic commercial agreement with Israels TeraGroup concerning SARS-CoV-2 research.

The Pluristem-Abu Dhabi Stem Cells Center MoU was signed in a video conference. But soon it may be possible to make a three-hour flight between the two Middle East countries. Israeli Prime Minister Benjamin Netanyahu said on Aug. 17 that Israel is working to enable flights between Israel and the United Arab Emirates to use Saudi airspace.

This article was first published by Israel21c.

Read the original:
Israelis and Emiratis to develop COVID-19 stem-cell therapy - JNS.org

Stem Cell Therapeutics Market | Industry Demand Status by Size, Progress Strategies, Manufacturers, Regions, Trends, Challenges, And Forecast by…

INC. and CAPRICOR THERAPEUTICS INC.

Market Dynamics :

>Drivers
>Restraints
>Opportunities
-

Based On Biological Analysis Stem Cell Therapeutics Market Report Covers Consumption Volume Analysis, Sales Volume, Performance and Share, Sales Price and Sales Revenue Analysis of Regions:

United States, Canada, Mexico, United Kingdom, France, Germany, Italy, Spain, Rest of Europe, India, China, Japan, Australia, South Korea, Rest of APAC, GCC, South Africa, Rest of MEA, Brazil,Argentina, Rest of South Africa

Key Developments in the Market:: > February 2018: Astellas Acquires Universal Cells, Inc. to create cell therapy products. > January 2018: Astellas Completes Acquisition of Mitobridge, Inc.

For More Information or Query or Customization Before Buying, Visit at https://www.industryresearch.co/enquiry/pre-order-enquiry/13102459

Important Questions Answered in the Report:

Highlighted points of Market Report:

Purchase this Report (Price 4250 USD for single-user license) https://www.industryresearch.co/purchase/13102459

Stem Cell Therapeutics Market Covers Following Points in TOC:

Chapter 1: Stem Cell Therapeutics Market Definition

Chapter 2: Research Methodology of Stem Cell Therapeutics Market

Chapter 3: Stem Cell Therapeutics Market Executive Summary

Chapter 4: Stem Cell Therapeutics Market Overview Includes Current Market Scenario, Porters Five Forces Analysis, Bargaining Power of Suppliers and Consumers, Threat of New Entrants and Substitute Product and Services

Chapter 5: Market Dynamics Covers Drivers, Restraints, Opportunities and Challenges

Chapter 6: Stem Cell Therapeutics Market Segmentation by Types, End-User, and Applications Forecast to 2023

Chapter 7: Stem Cell Therapeutics Market Segmentation by Geographical Regions

Chapter 8: Competitive Landscape of Stem Cell Therapeutics Market Includes Mergers & Acquisition Analysis, Agreements, Collaborations, and Partnerships, New Products Launches

Chapter 9: Key Players for Stem Cell Therapeutics Market

For Detailed TOC Click Here

Contact Us:

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [emailprotected]

Our Other Reports:

Healthcare Linen Market Size, Share and CAGR Status 2020 Global Industry Data by Top Manufacturers, Business Boosting Strategies, Upcoming Trends, Emerging Growth Factors till 2026

Ceramic Rod Market 2020 Global Industry Size Estimation, Research Update, Future Scope, Revenue, Pricing Trends, Growth Opportunity, Regional Outlook and Forecast to 2025

VoIP Software Market 2020 Industry Outlook by Business Share, Industry Price Trend, Size Estimation, Latest Research Report by Business Analysis and Forecast Research till 2025

Universal Power Line Carrier (UPLC) Market 2020: Global Industry Overview by Top Key Players Size, Share, Future Growth, Development, Revenue, and Growth Factors up to 2025

Dipentene (Limonene) Market 2020: Top Coverage of Key Companies with Size and Share, Expected Growth Analysis with Revenue, Future Trends and Technology Forecast by 2026

Autocrane Market Share 2020: Global Industry Outlook by Growth Segments, Types, Applications, and End-User Analysis Industry Size, Forecast to 2026

More:
Stem Cell Therapeutics Market | Industry Demand Status by Size, Progress Strategies, Manufacturers, Regions, Trends, Challenges, And Forecast by...